Polar Capital Holdings Plc
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1837309
London, X0
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$148,768,741
-$9,408,262 QoQ
Shares Held
192,546
-6.0% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Polar Capital Holdings Plc holds $3,129,351,296 across 43 Biotechnology names. REGN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
4,405,312 | $256,168,892 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
5,065,933 | $198,584,573 | |
| 3 | NUVL |
Nuvalent, Inc.
|
1,831,253 | $187,611,869 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
2,519,306 | $187,083,663 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
289,310 | $151,445,105 | |
| 6 | ASND |
Ascendis Pharma A/S
|
651,712 | $149,066,085 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
192,546 | $148,768,741 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,615,586 | $140,507,514 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $148,768,741 | 192,546 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $158,177,003 | 204,927 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $89,298,034 | 158,817 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $36,750,000 | 70,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,882,650 | 55,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $40,067,850 | 56,249 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $75,473,775 | 71,795 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $139,819,571 | 133,031 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $170,320,305 | 176,958 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $173,767,041 | 197,847 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $109,042,200 | 132,500 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $95,206,550 | 132,500 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $108,871,275 | 132,500 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $84,775,075 | 117,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $77,497,875 | 112,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $73,891,250 | 125,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $101,270,900 | 145,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $107,358,400 | 170,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $102,880,600 | 170,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $83,781,000 | 150,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $35,485,500 | 75,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,895,450 | 95,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||